 | Lyell Immunopharma, Inc. | |||
| NMS : LYEL || Location: United States | ||||
$2.40.0 (0.0%) |
0.12 M | 2.27 - 2.41 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 18.104 M |
| March 15, 2024 | 10.376 M |
| Feb. 29, 2024 | 10.954 M |
| Feb. 15, 2024 | 18.126 M |
| Jan. 31, 2024 | 10.840 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.23 | -0.20 | 14.02% |
| 09/30/2023 | -0.26 | -0.17 | 33.33% |
| 06/30/2023 | -0.28 | -0.18 | 35.44% |
| 03/31/2023 | -0.29 | -0.23 | 20.42% |
| 12/31/2022 | -0.31 | -0.04 | 87.07% |
LYEL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 254.096M | Shares Float | 163.348M |
| Short Float | 18.104M | Market Cap | 609.83M |
| Institution ownership | 72.88% | Insider ownership | 15.590% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.93 | Forward EPS | -0.89 |